DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Ishida H, Zhang X, Erickson K, Ray P.
Botulinum toxin type A targets RhoB to inhibit lysophosphatidic acid-stimulated actin reorganization and acetylcholine release in nerve growth factor-treated PC12 cells.
J Pharmacol Exp Ther 2004;
310 (3) 881-889
We do not assume any responsibility for the contents of the web pages of other providers.